Cargando…

miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

Purpose: The study of breast cancer nearly always involves patients close to menopause or older. Therefore, young patients are mostly underrepresented. Our aim in this study was to demonstrate biological differences in breast cancer of young people using as a model available cell lines derived from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oltra, Sara S, Peña-Chilet, Maria, Martinez, Maria T, Tormo, Eduardo, Cejalvo, Juan Miguel, Climent, Joan, Eroles, Pilar, Lluch, Ana, Ribas, Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716059/ https://www.ncbi.nlm.nih.gov/pubmed/33311984 http://dx.doi.org/10.1177/1178223420977845

Ejemplares similares

Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women
por: Oltra, Sara S., et al.
Publicado: (2018)

Construction of HCC-targeting artificial miRNAs using natural miRNA precursors
por: HUANG, XIAOMING, et al.
Publicado: (2013)

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women
por: Oltra, Sara S., et al.
Publicado: (2020)

MicroRNA profile in very young women with breast cancer
por: Peña-Chilet, Maria, et al.
Publicado: (2014)

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
por: Crippa, Elisabetta, et al.
Publicado: (2016)

Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis
por: Rui, Tao, et al.
Publicado: (2022)

Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937
por: Nyaga, Simon G, et al.
Publicado: (2006)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer
por: Cabello, Paula, et al.
Publicado: (2016)

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
por: Tassone, P, et al.
Publicado: (2003)

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
por: Lou, Weiyang, et al.
Publicado: (2019)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

The Anticancer Effects of Novel Imidazo[1,2-a]Pyridine Compounds against HCC1937 Breast Cancer Cells
por: Altaher, Akram M, et al.
Publicado: (2022)

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
por: Tormo, Eduardo, et al.
Publicado: (2019)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
por: Cheng, Chunxia, et al.
Publicado: (2020)

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene
por: Tormo, Eduardo, et al.
Publicado: (2017)

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
por: SALVI, ALESSANDRO, et al.
Publicado: (2012)

MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression
por: Zhang, Ying, et al.
Publicado: (2014)

Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis
por: Su, Zi-jian, et al.
Publicado: (2020)

Acceleration in the DNA methylation age in breast cancer tumours from very young women
por: Oltra, Sara S., et al.
Publicado: (2019)

Inflammatory Mechanisms of HCC Development
por: Refolo, Maria Grazia, et al.
Publicado: (2020)

Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

HCC surveillance results in earlier HCC detection: results from an Indian cohort
por: Kohli, Anita, et al.
Publicado: (2014)

Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator
por: Martínez, María Teresa, et al.
Publicado: (2019)

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
por: Kasinski, Andrea L, et al.
Publicado: (2012)

MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1
por: Liu, Ying, et al.
Publicado: (2014)

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
por: Pascut, Devis, et al.
Publicado: (2019)

Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622
por: Zou, Haibo, et al.
Publicado: (2019)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Sun, Na, et al.
Publicado: (2020)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
por: Manganelli, Michele, et al.
Publicado: (2021)

A Feedback Inhibition between miRNA-127 and TGFβ/c-Jun Cascade in HCC Cell Migration via MMP13
por: Yang, Zhihong, et al.
Publicado: (2013)

Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2019)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2csv32jle225s560vb81i9qllt